As of 2025-09-18, the Relative Valuation of Kezar Life Sciences Inc (KZR) is (117.46) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.74 USD, the upside of Kezar Life Sciences Inc based on Relative Valuation is -3240.5%.
The range of the Relative Valuation is (94.30) - (132.13) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 11.1x - 15.6x | 13.9x |
| Forward P/E multiples | 11.0x - 17.0x | 13.8x |
| Fair Price | (94.30) - (132.13) | (117.46) |
| Upside | -2621.5% - -3632.8% | -3240.5% |
| Date | P/E |
| 2025-09-17 | -0.45 |
| 2025-09-16 | -0.44 |
| 2025-09-15 | -0.46 |
| 2025-09-12 | -0.47 |
| 2025-09-11 | -0.47 |
| 2025-09-10 | -0.47 |
| 2025-09-09 | -0.47 |
| 2025-09-08 | -0.47 |
| 2025-09-05 | -0.48 |
| 2025-09-04 | -0.45 |
| 2025-09-03 | -0.46 |
| 2025-09-02 | -0.45 |
| 2025-08-29 | -0.47 |
| 2025-08-28 | -0.47 |
| 2025-08-27 | -0.47 |
| 2025-08-26 | -0.47 |
| 2025-08-25 | -0.47 |
| 2025-08-22 | -0.48 |
| 2025-08-21 | -0.47 |
| 2025-08-20 | -0.46 |
| 2025-08-19 | -0.46 |
| 2025-08-18 | -0.46 |
| 2025-08-15 | -0.47 |
| 2025-08-14 | -0.47 |
| 2025-08-13 | -0.46 |
| 2025-08-12 | -0.46 |
| 2025-08-11 | -0.46 |
| 2025-08-08 | -0.47 |
| 2025-08-07 | -0.47 |
| 2025-08-06 | -0.48 |
| 2025-08-05 | -0.48 |
| 2025-08-04 | -0.48 |
| 2025-08-01 | -0.48 |
| 2025-07-31 | -0.50 |
| 2025-07-30 | -0.51 |
| 2025-07-29 | -0.51 |
| 2025-07-28 | -0.51 |
| 2025-07-25 | -0.51 |
| 2025-07-24 | -0.53 |
| 2025-07-23 | -0.51 |
| 2025-07-22 | -0.52 |
| 2025-07-21 | -0.51 |
| 2025-07-18 | -0.51 |
| 2025-07-17 | -0.53 |
| 2025-07-16 | -0.53 |
| 2025-07-15 | -0.54 |
| 2025-07-14 | -0.54 |
| 2025-07-11 | -0.53 |
| 2025-07-10 | -0.56 |
| 2025-07-09 | -0.54 |